Benefits include lower risk for death and cardiovascular disease, diabetes, dementia, and depression. (HealthDay News) — Seven thousand steps per day is associated with clinically meaningful ...

SGLT2 inhibitor use was associated with an increased risk for erythrocytosis but not thrombosis among patients with type 2 diabetes.

The FDA has granted Fast Track designation to SAP-001 for the treatment of hyperuricemia in adult patients with gout who are refractory to conventional therapy.

The FDA has approved Empaveli for the treatment of adult and pediatric patients aged 12 years and older with C3G or primary IC-MPGN, to reduce proteinuria.

Authors say holistic treatment approaches may ease financial vulnerability for people with diabetes. (HealthDay News) — Patients with type 2 diabetes may experience substantially more adverse ...

Serial high-sensitivity troponin I measurements may help predict death in cancer patients treated with ICIs, data suggest.

Single-port robotic surgery sparked interest and debate at the American Urological Association annual meeting (AUA 2025).

(HealthDay News) — The initiation of dialysis in women with chronic kidney disease during pregnancy varies by clinical practice, signaling a need for standardized care in this population ...

Incidental prostate cancer is typically discovered after a benign prostatic hyperplasia procedure in older men. A study compared outcomes after primary treatment.

The group, known as the U.S. Preventive Services Task Force, is made up of doctors, nurses and public health experts.

Findings based on use cases of AI for diagnostic, therapeutic, and administrative purposes.

Cuts to Medicaid prompted by the One Big Beautiful Bill Act could lead to thousands of excess deaths each year.